Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05654532
Title Study of AC699 in Patients With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Locally Advanced or Metastatic Breast Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Accutar Biotechnology Inc
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Site 02 RECRUITING Sarasota Florida 34232 United States Details
Site 01 RECRUITING Nashville Tennessee 37203 United States Details
Site 03 RECRUITING Houston Texas 77030 United States Details
Site 05 RECRUITING Norfolk Virginia 23502 United States Details
Site 04 RECRUITING Vancouver Washington 98684 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field